Intellectual Property India Publishes Patent Application for 'Blocking ITGB8 In Neurodegenerative Disease' Filed by The Brigham And Women's Hospital, Inc.; and The Regents Of The University Of California

MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517036817 A) filed by The Brigham And Women's Hospital, Inc.; and The Regents Of The University Of California, Boston, on April 16, for 'blocking itgb8 in neurodegenerative disease.'

Inventor(s) include Atakilit, Amha; Butovsky, Oleg; Zhang, Xiaoming; Rosenzweig, Neta; Yin, Zhuoran; Sheppard, Dean; and Arnold, Thomas D.

The application for the patent was published on May 30, under issue no. 22/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are methods and compositions that block Integrin Subunit beta 8 (ITGB8, also known as integrin av8) to treat neurodegenerative diseases associated with microglial impairment including Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS)."

The patent application was internationally filed on Sept. 25, 2023, under International application No.PCT/US2023/075059.

Disclaimer: Curated by HT Syndication.